These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 15811552
1. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL). Suzuki N, Aoki M, Hinuma Y, Takahashi T, Onodera Y, Ishigaki A, Kato M, Warita H, Tateyama M, Itoyama Y. Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552 [Abstract] [Full Text] [Related]
6. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients. Au CG, Butler TL, Egan JR, Cooper ST, Lo HP, Compton AG, North KN, Winlaw DS. Acta Neuropathol; 2008 Sep 15; 116(3):235-46. PubMed ID: 18392839 [Abstract] [Full Text] [Related]
11. Characterisation of the dysferlin skeletal muscle promoter. Foxton RM, Laval SH, Bushby KM. Eur J Hum Genet; 2004 Feb 08; 12(2):127-31. PubMed ID: 14560310 [Abstract] [Full Text] [Related]
12. Common pathological mechanisms in mouse models for muscular dystrophies. Turk R, Sterrenburg E, van der Wees CG, de Meijer EJ, de Menezes RX, Groh S, Campbell KP, Noguchi S, van Ommen GJ, den Dunnen JT, 't Hoen PA. FASEB J; 2006 Jan 08; 20(1):127-9. PubMed ID: 16306063 [Abstract] [Full Text] [Related]
15. Loss of podocyte dysferlin expression is associated with minimal change nephropathy. Izzedine H, Brocheriou I, Eymard B, Le Charpentier M, Romero NB, Lenaour G, Bourry E, Deray G. Am J Kidney Dis; 2006 Jul 08; 48(1):143-50. PubMed ID: 16797397 [Abstract] [Full Text] [Related]
16. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Höger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A. Nat Genet; 1999 Oct 08; 23(2):141-2. PubMed ID: 10508505 [No Abstract] [Full Text] [Related]
18. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Leriche-Guérin K, Anderson LV, Wrogemann K, Roy B, Goulet M, Tremblay JP. Neuromuscul Disord; 2002 Feb 08; 12(2):167-73. PubMed ID: 11738359 [Abstract] [Full Text] [Related]
19. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF. Diers A, Carl M, Stoltenburg-Didinger G, Vorgerd M, Spuler S. Neuromuscul Disord; 2007 Feb 08; 17(2):157-62. PubMed ID: 17129727 [Abstract] [Full Text] [Related]
20. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies. Nguyen K, Bassez G, Bernard R, Krahn M, Labelle V, Figarella-Branger D, Pouget J, Hammouda el H, Béroud C, Urtizberea A, Eymard B, Leturcq F, Lévy N. Hum Mutat; 2005 Aug 08; 26(2):165. PubMed ID: 16010686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]